Market Place
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations. 
X
Please Wait
Applying Filters...
01 Dr. Reddy's Laboratories (1)
02 Aspen API (1)
03 Aspen Pharmacare Holdings (3)
04 NanoAlvand (1)
05 ARTHUR GRP (1)
06 Accord healthcare (2)
07 Accure Labs (2)
08 Actavis Inc (1)
09 American Regent (1)
10 Amneal Pharmaceuticals (1)
11 Apotex Inc (1)
12 Biem Ilac San. ve Tic. A.S (1)
13 Etico Lifesciences (1)
14 Eurolab (1)
15 Fresenius Kabi AB Brunna (1)
16 Fresenius Kabi Oncology Limited (1)
17 Fresenius SE & Co. KGaA (1)
18 Hospira, Inc. (1)
19 Meitheal Pharmaceuticals (1)
20 Nexus Pharmaceuticals (1)
21 Opocrin SpA (1)
22 Pharmascience Inc. (2)
23 Pierre Fabre (4)
24 STERIMAX INC (1)
25 Sakar Healthcare (1)
26 Shilpa Medicare (1)
27 TherDose Pharma (1)
28 Viatris (2)
29 Waylis Therapeutics (1)
01 Busulfano 60Mg 8 Joined The Parenteral Use (1)
02 CONCENTRATE FOR SOLUTION FOR INFUSION (2)
03 Concentrate to the infusion fluid, resolution (2)
04 FILMDRAGERAD TABLETT (1)
05 INF (2)
06 INJ (2)
07 INJECTABLE;INJECTION (14)
08 INJECTION (1)
09 Injectable Injection (1)
10 Injection (3)
11 SOLUTION (2)
12 Solution for IV Infusion (1)
13 TAB (1)
14 TABLET (2)
15 TABLET;ORAL (1)
16 Vial (1)
17 tablet (1)
01 DISCN (4)
02 Generic (5)
03 Lead Market Dossiers- Filed (1)
04 Originator (2)
05 Prescription (3)
06 RX (11)
07 Blank (12)
01 Accoran (1)
02 BUSPHALAN (1)
03 BUSULFAN (13)
04 BUSULFAN 6mg/ml FRESENIUS (1)
05 BUSULFAN FOR INJECTION (1)
06 BUSULFEX (1)
07 Busilvex (4)
08 Buslera (1)
09 Busulfan Fresenius Kabi (2)
10 MYLERAN (2)
11 Milosun (1)
12 Myleran (3)
13 PMS-BUSULFAN (1)
14 Vexfan (1)
15 Blank (5)
01 Australia (1)
02 Canada (3)
03 India (6)
04 Iran (1)
05 Italy (1)
06 Norway (2)
07 South Africa (5)
08 Sweden (3)
09 Turkey (1)
10 USA (15)
Iran Expo
Not Confirmed
Contact SupplierIran Expo
Not Confirmed
Contact SupplierIran Expo
Not Confirmed
Contact Supplier
